Jeremy A. Freeman

1.8k citations
21 papers · 1.4k indexed · h-index 13
Topics
Hepatitis C virus research (8 papers)Liver Disease Diagnosis and Treatment (5 papers)Salmonella and Campylobacter epidemiology (4 papers)

In The Last Decade

Jeremy A. Freeman

20 papers receiving 1.4k citations

Peers

Jeremy A. Freeman
Comparison fields: 5 of 85
  • Molecular Biology 672
  • Endocrinology 631
  • Genetics 363
  • Immunology 320
  • Food Science 266
Replace Holly Hamilton with:
Holly Hamilton United States
Guowei Yang China
Andrew Hessel Canada
Cristina Gil‐Cruz Switzerland
Manuel Osorio United States
Bisweswar Nandi United States
Ammi Grahn Sweden
P. Falk United States
A Hohmann Australia
Thierry Vasselon France
Jeremy A. Freeman relative to Holly Hamilton United States Holly Hamilton's profile →
Citations per field
00.5×8.3×
Holly Hamilton · 1×
Citations per year

Countries citing papers authored by Jeremy A. Freeman

Since Specialization
Citations

This map shows the geographic impact of Jeremy A. Freeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeremy A. Freeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeremy A. Freeman more than expected).

Fields of papers citing papers by Jeremy A. Freeman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeremy A. Freeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeremy A. Freeman. The network helps show where Jeremy A. Freeman may publish in the future.

Co-authorship network of co-authors of Jeremy A. Freeman

This figure shows the co-authorship network connecting the top 25 collaborators of Jeremy A. Freeman. A scholar is included among the top collaborators of Jeremy A. Freeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeremy A. Freeman. Jeremy A. Freeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 6
4 34
5 46
6 12
7 6
8 8
9 7
10 192
11 53
12 17
13 85
14 67
15 108
16 48
17 117
18 136
19 296
20 199

About Jeremy A. Freeman

Jeremy A. Freeman is a scholar working on Hepatology, Endocrinology and Rheumatology, having authored 21 papers that have together received 1.4k indexed citations. Recurring topics across this work include Hepatitis C virus research (8 papers), Liver Disease Diagnosis and Treatment (5 papers) and Salmonella and Campylobacter epidemiology (4 papers). The work is most often cited by research in Endocrinology (631 citations), Hepatology (209 citations) and Immunology (320 citations). Jeremy A. Freeman has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Bonnie L. Bassler, Samuel I. Miller, Brendan N. Lilley, Michael Ohl, Michael Hensel, Diana F. Hausman, David Fontana, Kelly Byrnes-Blake, Werner Schröder and Jörg Deiwick. Their work appears in journals such as Blood, Hepatology and Journal of Bacteriology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026